Alzheimer's Association campaigns for broader Leqembi coverage — FDA reverses course; will hold adcomm for Sarepta’s DMD gene therapy— Pfizer and Astellas report positive data from prostate cancer therapy trial -- See more on our front page news http://bit.ly/w28kSd #alzheimers #eisai #biogen #fda #dmd #duchenne #pfizer #astellas #clinicaltrials #prostatecancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#alzheimers #eisai #biogen #FdA #dmd #Duchenne #pfizer #astellas #clinicaltrials #ProstateCancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Duchenne muscular dystrophy: major trials and events to watch in 2023 — Biogen gets EU court ruling in favor of blocking Tecfidera generic entry— FDA offers radio silence on question of spring Covid boosters -- See more on our front page news http://bit.ly/w28kSd #dmd #duchenne #fda #clinicaltrials #europe #generics #biogen #multiplesclerosis #ms #covid #covid19 #vaccines #boosters #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#dmd #Duchenne #FdA #clinicaltrials #europe #generics #biogen #multiplesclerosis #ms #covid #covid19 #vaccines #boosters #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
The tragic death of Terry Horgan, a 27-year-old who had #Duchenne muscular dystrophy and was partway through a clinical trial involving #CRISPR. At this point, it’s unclear whether the treatment or the disease itself contributed to his death. https://fortune.com/2022/11/04/crispr-gene-editing-experimental-trial-volunteer-dies-terry-horgan-dmd/